VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 2.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $73,946 | -6.9% | 11,221 | -4.0% | 0.00% | 0.0% |
Q1 2023 | $79,402 | -9.4% | 11,694 | -1.4% | 0.00% | 0.0% |
Q4 2022 | $87,645 | -21.0% | 11,860 | +5.4% | 0.00% | 0.0% |
Q3 2022 | $111,000 | +7.8% | 11,253 | +18.6% | 0.00% | 0.0% |
Q2 2022 | $103,000 | +13.2% | 9,488 | +18.2% | 0.00% | 0.0% |
Q1 2022 | $91,000 | -23.5% | 8,028 | +5.5% | 0.00% | 0.0% |
Q4 2021 | $119,000 | -6.3% | 7,612 | +2.6% | 0.00% | 0.0% |
Q3 2021 | $127,000 | -25.3% | 7,420 | -6.1% | 0.00% | -50.0% |
Q2 2021 | $170,000 | +54.5% | 7,899 | +7.8% | 0.00% | +100.0% |
Q1 2021 | $110,000 | +22.2% | 7,329 | +6.8% | 0.00% | 0.0% |
Q4 2020 | $90,000 | +40.6% | 6,860 | +4.2% | 0.00% | 0.0% |
Q3 2020 | $64,000 | +113.3% | 6,582 | +149.2% | 0.00% | – |
Q2 2020 | $30,000 | +25.0% | 2,641 | +14.0% | 0.00% | – |
Q1 2020 | $24,000 | -22.6% | 2,316 | +22.3% | 0.00% | – |
Q4 2019 | $31,000 | +19.2% | 1,893 | -3.7% | 0.00% | – |
Q3 2019 | $26,000 | -3.7% | 1,965 | +3.5% | 0.00% | – |
Q2 2019 | $27,000 | -3.6% | 1,898 | +25.3% | 0.00% | – |
Q1 2019 | $28,000 | -17.6% | 1,515 | +16.4% | 0.00% | -100.0% |
Q4 2018 | $34,000 | – | 1,302 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |